Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (191-200 of 335) with videos related to

Pageof 34
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 25, 2020
Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trialsPeter A Schneider, Marianne Brodmann, Laura Mauri, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary interventionJason H Wasfy, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Sources of hospital variation in short-term readmission rates after percutaneous coronary interventionRobert W Yeh, Kenneth Rosenfield, Katya Zelevinsky, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery diseaseAjay J Kirtane, Rikesh Patel, Charles O'Shaughnessy, et al.
American Heart Journal|May 27, 2003
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART)Laura Mauri, Mark Reisman, Maurice Buchbinder, et al.
American Heart Journal|September 16, 2018
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary interventionLaura Mauri, Ajay J Kirtane, Stephan Windecker, et al.
The American Journal of Cardiology|May 29, 2004
Effects of stent length and lesion length on coronary restenosisLaura Mauri, A James O'Malley, Donald E Cutlip, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2017
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2015
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramMohamed Abdel-Wahab, Franz-Joseph Neumann, Patrick Serruys, et al.
Pageof 34

Showing results (191-200 of 335) with videos related to

Sort By:
Pageof 34
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 25, 2020
Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trialsPeter A Schneider, Marianne Brodmann, Laura Mauri, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary interventionJason H Wasfy, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Sources of hospital variation in short-term readmission rates after percutaneous coronary interventionRobert W Yeh, Kenneth Rosenfield, Katya Zelevinsky, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery diseaseAjay J Kirtane, Rikesh Patel, Charles O'Shaughnessy, et al.
American Heart Journal|May 27, 2003
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART)Laura Mauri, Mark Reisman, Maurice Buchbinder, et al.
American Heart Journal|September 16, 2018
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary interventionLaura Mauri, Ajay J Kirtane, Stephan Windecker, et al.
The American Journal of Cardiology|May 29, 2004
Effects of stent length and lesion length on coronary restenosisLaura Mauri, A James O'Malley, Donald E Cutlip, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2017
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2015
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramMohamed Abdel-Wahab, Franz-Joseph Neumann, Patrick Serruys, et al.
Pageof 34